This move is archived. Current quotes and coverage live on the stock page.
Follow APLI
Appili Therapeutics Inc experienced a remarkable surge in stock value, climbing by an impressive 50% in yesterday's trading session.
Investors in Appili Therapeutics Inc (APLI.TO) saw significant gains as the stock surged by 50% in yesterday's session, closing at CA$0.01. This sharp increase highlights a potential shift in market sentiment towards the company's strategic direction.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$661,830
52W high
$0.03
52W low
$0.01
1W change
-50.00%
Beta
-0.19
Analyst Price Targets
Based on analyst covering APLI · as of Sep 17, 2026
Wall Street analysts forecast APLI stock price to rise 2900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+2900.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
473.3%
Annualized
90-Day Vol
313.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.00 | C$0.00 – C$0.02 |
| 60 trading days | C$0.00 | C$0.00 – C$0.04 |
| 90 trading days | C$0.00 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The surge in Appili's stock price could indicate growing investor confidence in the company's new business strategy focused on the biodefence sector.
50% Surge in Stock Price
Appili Therapeutics Inc's stock price jumped from CA$0.0067 to CA$0.01, reflecting a significant increase in investor interest.
Bull case
The positive momentum may be due to Appili's shift towards biodefence, which could open up new revenue streams and attract more funding.
Bear case
Even with the recent gains, investors should stay cautious. The company's market cap is still relatively low, and there haven't been any recent announcements that could keep this momentum going.
Market Reaction to Appili's Strategy
Advertisement
The 50% increase in Appili's stock price yesterday suggests that investors are responding positively to the company's new focus on the biodefence sector. As the company shifts its strategy, this could lead to increased revenue and partnerships in a growing market.
Understanding the Financial Landscape
With a market cap of just over CA$1.3 million, Appili's stock remains highly speculative. Investors should consider the recent surge in light of the company's financial health and operational results. The lack of recent news may pose a risk to sustaining this momentum.
Future Outlook for Appili Therapeutics
As Appili Therapeutics Inc continues to navigate its strategic changes, investors will be watching closely for any developments that could impact its stock performance. The focus on biodefence could provide opportunities, but the company must execute effectively to maintain investor confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
